New Key Statistics Module, Z-Score and F-Score
BUE:GSK Key Ratios
Market Cap ARS M | 74,725,662.17 |
Enterprise Value ARS M | 88,990,253.81 |
P/E(ttm) | 14.86 |
PE Ratio without NRI | 13.57 |
Forward PE Ratio | 13.21 |
Price/Book | 5.08 |
Price/Sales | 2.37 |
Price/Free Cash Flow | 16.10 |
Price/Owner Earnings | 12.07 |
Payout Ratio % | 0.47 |
Revenue (TTM) ARS M | 11,049,596.00 |
EPS (TTM) ARS | 188.39 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 1.00 |
y-y EBITDA Growth Rate % | 4.90 |
EV-to-EBIT | 11.97 |
EV-to-EBITDA | 8.95 |
PEG | 13.57 |
Shares Outstanding M | 8,172.13 |
Net Margin (%) | 16.25 |
Operating Margin % | 24.22 |
Pre-tax Margin (%) | 20.00 |
Quick Ratio | 0.62 |
Current Ratio | 0.88 |
ROA % (ttm) | 8.27 |
ROE % (ttm) | 40.01 |
ROIC % (ttm) | 12.70 |
Dividend Yield % | 1.89 |
Altman Z-Score | 1.90 |
BUE:GSK Number of Guru Trades
BUE:GSK Volume of Guru Trades
Gurus Latest Trades with BUE:GSK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BUE:GSK is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data